
Ibolme Trio Tablet
Marketer
Indiabulls pharmaceutical ltd
Salt Composition
Olmesartan Medoxomil (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Ibolme Trio Tablet
For patients with hypertension unresponsive to monotherapy, Ibolme Trio Tablets offer a combined approach to blood pressure management. This medication effectively lowers elevated blood pressure, thereby mitigating the risk of future strokes and heart attacks. Dosage is individualized, administered with or without food, and ideally taken consistently at the same time daily. Continuous use, as directed by your physician, is crucial; premature discontinuation elevates the risk of cardiovascular events. Containing a diuretic, increased urination is expected, prompting avoidance of late-evening administration (within four hours of bedtime). Regular intake, even during asymptomatic periods, maximizes therapeutic benefit, as hypertension often presents subtly. Common side effects, including edema, cephalalgia, vertigo, fatigue, and altered taste perception, warrant consultation with your doctor if persistent, worsening, or bothersome. Adequate hydration helps alleviate potential side effects like muscle weakness, xerostomia, and polydipsia. Prior to commencing treatment, disclose any pre-existing renal or hepatic conditions, and pregnant or lactating individuals must seek medical counsel. Complete disclosure of all concurrent medications, particularly those for hypertension or cardiac conditions, is essential. Regular monitoring of blood pressure, renal function, electrolyte levels, and glycemia ensures optimal therapeutic efficacy and safety.
Primary Ingredients of Ibolme Trio Tablet
The provided text is "undefined". Therefore, no rephrasing is possible.
Uses of Ibolme Trio Tablet
Elevated blood pressure
Major Benefits of Ibolme Trio Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Ibolme Trio Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Ibolme Trio Tablet:
- Headache
- Dizziness
- Nausea
- Upper respiratory tract infection
- Fatigue
- Urinary tract infection
- Diarrhea
- Joint swelling
- Peripheral edema
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Muscle spasm
- Hypotension (low blood pressure)
- Increased creatinine level in blood
- Increased blood urea
- Increased uric acid level in blood
How to use Ibolme Trio Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The tablets should be swallowed whole; do not break, crush, or chew them. Ibolme Trio Tablets can be taken with or without food, however, consistent timing is recommended.
How Ibolme Trio Tablet works:
Ibolme Trio Tablet unites three distinct medications: Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide. Olmesartan Medoxomil, an angiotensin II receptor antagonist, and Amlodipine, a calcium channel blocker, synergistically dilate blood vessels, thus reducing blood pressure. Hydrochlorothiazide, a diuretic, promotes fluid excretion via the urinary tract, concurrently contributing to vasodilation and enhanced circulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Ibolme Trio Tablet is not advisable.
PregnancyCONSULT YOUR DOCTOR
Using Ibolme Trio Tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Ibolme Trio Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Ibolme Trio Tablets might lead to adverse reactions that impair driving ability. These reactions can include dizziness, headaches, nausea, or fatigue, potentially affecting concentration and safe driving.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Ibolme Trio Tablets, potentially requiring a modified dosage. Physician consultation is advised. Ibolme Trio Tablets are not recommended for individuals with severely compromised kidney function.
LiverCAUTION
Patients with hepatic impairment should use Ibolme Trio Tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended.
What if you forget to take Ibolme Trio Tablet :
Should you forget a dose of Ibolme Trio Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ibolme Trio Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Heart |
